Advertisement
Advertisement

PRE

PRE logo

Prenetics Global Limited Class A Ordinary Share

17.57
USD
Sponsored
-0.42
-2.33%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

17.71

+0.14
+0.80%

Prenetics Global Limited Class A Ordinary Share Profile

About

Prenetics, a leading genomics-driven health sciences company, is revolutionizing prevention, early detection, and treatment. Their prevention arm, CircleDNA, uses whole exome sequencing to offer the world's most comprehensive consumer DNA test. Insighta, their joint venture with renowned scientist Prof. Dennis Lo, underscores their unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Lastly, ACT Genomics, their treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances their global impact on health, truly embodying their commitment to 'enhancing life through science'.

Info & Links

CEO

Danny Sheng Wu Yeung

Headquarters

Unit 703-706, K11 Atelier King�s Road, 728 King�s Road
Quarry Bay, K3 00000, HONG KONG

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.prenetics.com

Auditor

Deloitte Touche Tohmatsu

Share holders

--

Employees

98

Prenetics Global Limited Class A Ordinary Share Statistics

Valuation Measures

Market Capitalization2

301.08M

Enterprise Value

268.95M

Enterprise Value/EBITDA(ttm)

-6.05

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.09

Price to Book(mrq)

1.68

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

46.15%

Operating Margin(ttm)

-32.46%

Profit Margin(ttm)

-62.94%

Return on Equity(ttm)

-19.07%

Return on Invested Capital(ttm)

-31.14%

Return on Assets(ttm)

-15.38%

Income Statement

Revenue(ttm)

92.39M

Revenue Per Share(ttm)

5.48

Gross Profit(ttm)

48.79M

EBITDA(ttm)3

-44.48M

Net Income Available to Common(ttm)

-37.71M

Diluted EPS(ttm)

-4.02

Share Statistics

Beta (5Y Monthly)

0.27

52-Week Change

228.41%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

16.87M

Dividend Yield

0.00%

Float4

15.52M

% Held by Insiders

7.80%

% Held by Institutions

25.01%

Balance Sheet

Total Cash(mrq)

32.13M

Total Cash Per Share(mrq)

1.90

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.67%

Quick Ratio(mrq)

2.76%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement